| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features.
|
J Clin Oncol
|
1993
|
2.77
|
|
2
|
The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
|
Haematologica
|
1998
|
1.66
|
|
3
|
Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity.
|
Cancer
|
1998
|
1.58
|
|
4
|
Risk of second cancers in Waldenström macroglobulinemia.
|
Ann Oncol
|
2011
|
1.47
|
|
5
|
Quantitative evaluation of erythropoietic activity in dysmyelopoietic syndromes.
|
Br J Haematol
|
1982
|
1.27
|
|
6
|
Isolated hyperferritinemia with normal transferrin saturation and dysmetabolism, in the absence of the two known mutations in the HFE gene of hereditary hemochromatosis.
|
Haematologica
|
1999
|
1.12
|
|
7
|
Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.
|
Br J Cancer
|
2004
|
1.11
|
|
8
|
Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients.
|
J Clin Oncol
|
1997
|
1.05
|
|
9
|
[Malaria in military personnel: the case of the Ivory Coast in 2002-2003].
|
Med Trop (Mars)
|
2003
|
1.05
|
|
10
|
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study.
|
Ann Oncol
|
2011
|
1.02
|
|
11
|
Rituximab (IDEC-C2B8): validation of a sensitive enzyme-linked immunoassay applied to a clinical pharmacokinetic study.
|
Ther Drug Monit
|
2000
|
1.02
|
|
12
|
Mediastinal B-cell lymphoma: a study of its histomorphologic spectrum based on 109 cases.
|
Hum Pathol
|
1999
|
0.94
|
|
13
|
Translocation (8;16) in a patient with acute myelomonocytic leukemia, occurring after treatment with fludarabine for a low-grade non-Hodgkin's lymphoma.
|
Haematologica
|
2000
|
0.94
|
|
14
|
The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders.
|
Br J Haematol
|
1999
|
0.93
|
|
15
|
Chronic myelomonocytic leukemia: clinical features, cytogenetics, and prognosis in 30 consecutive cases.
|
Hematol Oncol
|
1985
|
0.93
|
|
16
|
A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma.
|
Br J Haematol
|
2002
|
0.88
|
|
17
|
Managing twins discordant for fetal anomaly.
|
Prenat Diagn
|
2005
|
0.87
|
|
18
|
Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patients.
|
Haematologica
|
2001
|
0.87
|
|
19
|
Erythropoiesis in myelofibrosis with myeloid metaplasia: recognition of different classes of patients by erythrokinetics.
|
Br J Haematol
|
1981
|
0.85
|
|
20
|
P-VEBEC: a new 8-weekly schedule with or without rG-CSF for elderly patients with aggressive non-Hodgkin's lymphoma (NHL).
|
Ann Oncol
|
1994
|
0.83
|
|
21
|
A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma.
|
Bone Marrow Transplant
|
2004
|
0.83
|
|
22
|
Previously irradiated areas spared from skin toxicity induced by cetuximab in six patients: implications for the administration of EGFR inhibitors in previously irradiated patients.
|
Ann Oncol
|
2006
|
0.83
|
|
23
|
Impact of B-cell count and imaging screening in cMBL: any need to revise the current guidelines?
|
Leukemia
|
2012
|
0.83
|
|
24
|
Primary mediastinal B-cell lymphoma: update of its clinicopathologic features.
|
Leuk Lymphoma
|
1997
|
0.83
|
|
25
|
Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pretreated low-grade non-Hodgkin's lymphoma.
|
Ann Oncol
|
1999
|
0.83
|
|
26
|
Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer.
|
Ann Oncol
|
2011
|
0.82
|
|
27
|
Efficacy of pipobroman in the treatment of polycythemia vera: long-term results in 163 patients.
|
Haematologica
|
2000
|
0.82
|
|
28
|
Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial.
|
Ann Oncol
|
2014
|
0.81
|
|
29
|
Bone marrow and blood involvement by non-Hodgkin's lymphoma: a study of clinicopathologic correlations and prognostic significance in relationship to the Working Formulation.
|
Eur J Haematol
|
1989
|
0.81
|
|
30
|
Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radio-therapy: analysis of efficacy and long-term toxicity.
|
Haematologica
|
2000
|
0.79
|
|
31
|
Mitoxantrone and etoposide: an effective regimen for refractory or relapsed acute myelogenous leukemia.
|
Eur J Haematol
|
1989
|
0.78
|
|
32
|
A long-term time course of colorimetric assessment of the effects of imatinib mesylate on skin pigmentation: a study of five patients.
|
J Eur Acad Dermatol Venereol
|
2007
|
0.78
|
|
33
|
Adult acute lymphoblastic leukemia. Response to therapy according to presenting features in 62 patients.
|
Eur J Cancer Clin Oncol
|
1982
|
0.78
|
|
34
|
Risk assessment in myelodysplastic syndromes: value of clinical, hematologic and bone marrow histologic findings at presentation.
|
Eur J Haematol
|
1990
|
0.77
|
|
35
|
The role of systemic high-dose cytarabine in the treatment of central nervous system leukemia. Clinical results in 46 patients.
|
Cancer
|
1993
|
0.77
|
|
36
|
Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease.
|
Ann Oncol
|
1994
|
0.77
|
|
37
|
Transient response of myeloma clone to pamidronate therapy.
|
Haematologica
|
1999
|
0.77
|
|
38
|
Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis.
|
Ann Oncol
|
2014
|
0.77
|
|
39
|
Central nervous system (CNS) leukemia: the role of high dose cytarabine (HDAra-C).
|
Bone Marrow Transplant
|
1989
|
0.76
|
|
40
|
Treatment of terminal-phase chronic myelogenous leukemia with intermediate-dose cytarabine and hydroxyurea.
|
Hematol Oncol
|
1992
|
0.75
|
|
41
|
Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
|
J Clin Oncol
|
1986
|
0.75
|
|
42
|
Adult Ki-1-positive large cell anaplastic lymphoma presenting with skin lesions.
|
Acta Haematol
|
1989
|
0.75
|
|
43
|
Management of patients with implantable cardioverter defibrillator needing radiation therapy for cancer.
|
Br J Anaesth
|
2012
|
0.75
|
|
44
|
[The stretcher for the transportation of the critical patient, intensive transport unit (ITU): 2 years' experience].
|
Minerva Anestesiol
|
1991
|
0.75
|
|
45
|
[Limitations of the Italian Institute of Statistics' surveys in automobile accidents].
|
Chir Ital
|
1986
|
0.75
|
|
46
|
Low-dose arabinosyl cytosine in acute leukemia after a myelodysplastic syndrome and in elderly leukemia.
|
Am J Hematol
|
1985
|
0.75
|
|
47
|
Secondary acute myeloid leukemia following treatment with VP16-containing regimens for non-Hodgkin's lymphoma.
|
Haematologica
|
1998
|
0.75
|
|
48
|
Treatment with recombinant human erythropoietin (rHuEpo) in a patient with paroxysmal nocturnal haemoglobinuria: evaluation of membrane proteins CD55 and CD59 with cytofluorometric assay.
|
Br J Haematol
|
1997
|
0.75
|
|
49
|
[Granulocyte transfusion in patients with acute myeloid leukemia subjected to induction chemotherapy: prophylaxis or therapy?].
|
Riv Emoter Immunoematol
|
1984
|
0.75
|
|
50
|
Iron loading in beta-thalassaemia.
|
Lancet
|
1980
|
0.75
|
|
51
|
[Incidence of mycotic infections in patients with acute myeloid leukemia. Evaluation of the drug sensitivity of the isolated strains].
|
G Ital Chemioter
|
1986
|
0.75
|
|
52
|
[Early gastric cancer (case contribution)].
|
Chir Ital
|
1986
|
0.75
|
|
53
|
Cyclosporine in the treatment of aplastic anaemia and pure red-cell aplasia.
|
Bone Marrow Transplant
|
1989
|
0.75
|
|
54
|
Quantitative assessment of erythropoiesis in haemolytic disease.
|
Br J Haematol
|
1980
|
0.75
|
|
55
|
[Pulmonary aspergillosis in acute leukemia. Description of a case and review of the literature].
|
Minerva Med
|
1989
|
0.75
|
|
56
|
Serum levels of 3,5,3'-triiodothyronine, 3,3',5'-triiodothyronine and thyroxine in acute myocardial infarction.
|
Ric Clin Lab
|
1980
|
0.75
|
|
57
|
Empiric antibiotic association in the management of febrile episodes in patients submitted to bone marrow transplantation.
|
Bone Marrow Transplant
|
1989
|
0.75
|
|
58
|
[The atrial esophagocardiogram in the mitral prolapse syndrome].
|
Boll Soc Ital Cardiol
|
1977
|
0.75
|
|
59
|
[The plasma 59Fe clearance curve in man. An evaluation of methods of measurement and analysis].
|
Blut
|
1980
|
0.75
|
|
60
|
[Use of satellites for public health purposes in tropical areas].
|
Med Trop (Mars)
|
2003
|
0.75
|
|
61
|
[A new system of transportation of critical patients].
|
Minerva Anestesiol
|
1990
|
0.75
|
|
62
|
Undifferentiated nasopharyngeal carcinoma in children and adolescents: comparison between staging systems.
|
Ann Oncol
|
2001
|
0.75
|
|
63
|
Unusual widespread cutaneous eruption due to nilotinib therapy for chronic myeloid leukemia.
|
G Ital Dermatol Venereol
|
2014
|
0.75
|
|
64
|
Analysis of long-term results and prognostic factors among 138 patients with advanced Hodgkin's disease treated with the alternating MOPP/ABVD chemotherapy.
|
Ann Oncol
|
1994
|
0.75
|
|
65
|
Non-tropical idiopathic splenomegaly. Report of a case.
|
Haematologica
|
1982
|
0.75
|
|
66
|
[Antimycotic prophylaxis with oral amphotericin B in patients with acute myeloid leukemia].
|
Clin Ter
|
1986
|
0.75
|
|
67
|
A low serum beta 2-microglobulin level despite bulky tumor is a characteristic feature of primary mediastinal (thymic) large B-cell lymphoma: implications for serologic staging.
|
Eur J Haematol
|
1996
|
0.75
|
|
68
|
[Endobrachyesophagus as a sequel of esophagitis due to caustics].
|
Chir Ital
|
1986
|
0.75
|
|
69
|
[Injuries caused by seat belts].
|
Chir Ital
|
1986
|
0.75
|
|
70
|
[Characteristics of abortion in Chile].
|
Cuad Econ Soc
|
1978
|
0.75
|
|
71
|
[Emergencies in carcinoma of the esophagus].
|
Chir Ital
|
1986
|
0.75
|
|
72
|
Hemorrhagic and thrombotic complications in polycythemia vera. A clinical study.
|
Haematologica
|
1989
|
0.75
|
|
73
|
Hematologic and clinical features of patients with chromosome 5 monosomy or deletion (5q).
|
Med Pediatr Oncol
|
1988
|
0.75
|
|
74
|
Idarubicin in patients with diffuse large cell lymphomas: a randomized trial comparing VACOP-B (A = doxorubicin) vs VICOP-B (I = idarubicin).
|
Haematologica
|
1997
|
0.75
|
|
75
|
Therapy-related ovarian dysfunction in women treated for Hodgkin's disease.
|
Haematologica
|
1986
|
0.75
|
|
76
|
CAV chemotherapy (CCNU, melphalan, etoposide) as salvage treatment for relapsing or resistant Hodgkin's disease.
|
Haematologica
|
1991
|
0.75
|
|
77
|
Body size perception and dissatisfaction in female subjects of different ages.
|
Psychother Psychosom
|
1995
|
0.75
|
|
78
|
[Prolactin: physiology, pathological aspects and therapy].
|
Recenti Prog Med
|
1978
|
0.75
|
|
79
|
Red cell production and destruction in haemoglobin H disease.
|
Haematologica
|
1980
|
0.75
|
|
80
|
Allogeneic versus autologous bone marrow transplantation versus intensive post-remission chemotherapy in acute leukaemias.
|
Bone Marrow Transplant
|
1989
|
0.75
|
|
81
|
HIV-related thrombocytopenic purpura: a study of 24 cases.
|
Haematologica
|
1989
|
0.75
|
|
82
|
Lymphoblastic lymphoma in adult patients: clinicopathological features and response to intensive multiagent chemotherapy analogous to that used in acute lymphoblastic leukemia.
|
Ann Oncol
|
1990
|
0.75
|
|
83
|
[Intensive transport unit (ITU); a complete transportation system for the critical patient].
|
Minerva Anestesiol
|
1991
|
0.75
|
|
84
|
The use of 59Fe for estimating red cell production and destruction: a comparative evaluation of two methods for the analysis of experimental data.
|
Haematologica
|
1979
|
0.75
|
|
85
|
[Injuries caused by traffic accidents: passive safety and restraint systems in automobiles].
|
Chir Ital
|
1986
|
0.75
|
|
86
|
Erythropoiesis in hairy cell leukaemia: a true erythroid failure.
|
Scand J Haematol
|
1982
|
0.75
|
|
87
|
[Hepatitic complications and transfusional support in the remission-induction treatment of acute myeloid leukemia. Clinical study of l22 cases].
|
Riv Emoter Immunoematol
|
1985
|
0.75
|
|
88
|
[Restraint systems for children transported in automobiles].
|
Chir Ital
|
1986
|
0.75
|
|
89
|
Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy.
|
Ann Oncol
|
1994
|
0.75
|
|
90
|
Burkitt's lymphoma/leukemia: a clinicopathologic study on 24 adult patients.
|
Leukemia
|
1991
|
0.75
|
|
91
|
[Pharmacodynamic and forced test of the atrial esophagocardiogram as to its subsidiary diagnostic value in mitral valve insufficiency].
|
Boll Soc Ital Cardiol
|
1976
|
0.75
|
|
92
|
Leukemic phase of non-Hodgkin's lymphomas. Hematological features and prognostic significance.
|
Haematologica
|
1984
|
0.75
|